These innovative liposomes are designed to incorporate anti-CD8B antibodies, allowing them to specifically latch onto CD8+ T cells within the tumor microenvironment. This targeting mechanism could significantly enhance the efficacy of immunotherapeutic strategies against melanoma by ensuring that therapeutic agents are precisely delivered to the appropriate immune cells. As a result, the focused delivery of these drugs has the potential to not only stimulate a stronger anti-tumor immune response but also improve the overall effectiveness of cancer treatments, ultimately leading to better patient outcomes.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-1604MZ | Recombinant Mouse Anti-Rat CD8B Antibody (clone 452) | FC, IHC-P, IP, WB | Mouse antibody |
FAMAB-0012-CN | Mouse Anti-CD8B Recombinant Antibody (clone EP42) | FC | Mouse IgG |
FN-198CQ | Mouse Anti-CD8B Recombinant Antibody (clone 341) | Neut, FC, FuncS, IHC-P | Mouse IgG1, κ |
HPAB-S0182-YC | Rat Anti-Cd8b1 Recombinant Antibody (clone YTS156.7.7) | Neut | Rat IgG |
VS-0224-XY29 | Monkey Anti-CD8B Recombinant Antibody (VS-0224-XY29) | Depletion, In vivo assay | Monkey IgG1 |
There are currently no Customer reviews or questions for VS-1024-FY170. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.